Amarin (AMRN) Could See Action on Takeover Report

October 24, 2012 6:41 AM EDT
Amarin Corporation plc (NASDAQ: AMRN) could see action Wednesday following reports from the UK's Daily Mail that AstraZeneca (NYSE: AZN) plans to launch a bid for the company.

While certainly to create a stir, the article appear very speculative in nature. That, and the fact that takeover speculation has been surrounding the name for months could keep a lid on things. Also, shares of Amarin rose 4.7 percent Tuesday on - you guessed it - takeover speculation.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk


not really
cloo on 2012-10-24 08:54:47
Mark as Spam | Reply to this comment

Tuesday's rally was on the issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa. One more patent next Friday. Don't think AZN can properly price buyout until NCE resolved which may be waiting for these patents.

Add Your Comment